Products

Leadschilly

AI-native

More site visits from the leads you already pay for.

leadschilly.com Sales / AI SDR Agents

AI Benchmark
Desktop
Mobile
Monthly visits
<5K
Oct 2026
Public revenue
Undisclosed
No public revenue evidence yet
Entry price
Unknown
No monthly subscription pricing
Creators
Deep1010
@leadschilly· 85 followers
Launched
4y ago
2021-12-13 · Est.

Traffic

Monthly visitsData through Oct 2026

Marketing moves

Launches, search & content, referrals, promotions
X accounts@leadschilly
  • New product launchLaunch

    Dec 13, 2021 · 4y agoWebsite

Traffic sources

Oct 2026

Traffic breakdown

Channels

No data yet

Countries

No data yet

Search

Domain authority —Domain registered 2021-12-13

KeywordMonthly volume
smma19.1K
write a review1,710
smma meaning1,400
what is smma1,290
smma full form940

Traffic data: Vaneform

Pricing

Starter
Contact sales
Up to 3 users
Growth
Contact sales
Up to 10 users
Pro
Contact sales
Up to 25 users

Trial: Start with a free 30-day pilot on your own leads. · Enterprise custom tier · Observed 2026-11-04 · Pricing page

Pages & changes

Tracked since 2026-08-08

Key pages

Weekly snapshots
leadschilly.com/ Snapshot 2026-11-04

Changes

No pricing, plan, or positioning changes detected since tracking started.

Questions & evidence

How much does Leadschilly cost?
Starter: Contact sales; Growth: Contact sales; Pro: Contact sales. Observed 2026-11-04. Check the source for current billing terms, usage limits and taxes.Source
How much website traffic does Leadschilly get?
Vaneform estimates <5K website visits in 2026-10. Visits can include repeat visits; this estimate measures web traffic separately from paying customers or revenue.Source
What is Leadschilly and what platforms does it support?
Leadschilly is catalogued under AI SDR Agents: More site visits from the leads you already pay for.. Supported platforms: Mobile App.

Related products in this category

Sales / AI SDR Agents

These products share a catalog category. Compare customer tasks, features and deployment requirements before treating them as alternatives.